Raul C. Ribeiro

Hematology | Oncology

262 Danny Thomas Pl
Memphis, TN 38105

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 233 publications

DNA Methylation of Pharmacologic and Leukemia-Related Genes Predicts Clinical Outcomes in Pediatric Acute Myeloid Leukemia.

DNA Methylation of Pharmacologic and Leukemia-Related Genes Predicts Clinical Outcomes in Pediatric Acute Myeloid Leukemia.

Journal: Cancers

Published: June 23, 2026

Traumatic lumbar puncture at diagnosis in children and adolescents with acute lymphoblastic leukemia.

Traumatic lumbar puncture at diagnosis in children and adolescents with acute lymphoblastic leukemia.

Journal: Leukemia

Published: March 27, 2026

Pediatric blastic plasmacytoid dendritic cell neoplasms are molecularly defined by recurrent MYB rearrangements: clinical and molecular insights.

Pediatric blastic plasmacytoid dendritic cell neoplasms are molecularly defined by recurrent MYB rearrangements: clinical and molecular insights.

Journal: Haematologica

Published: March 17, 2026

Gilteritinib + chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

Gilteritinib + chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

Journal: Blood advances

Published: February 19, 2026

Gilteritinib and chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

Gilteritinib and chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

Journal: Blood advances

Published: February 19, 2026

G6PD activity in pediatric patients with the G6PD Ilesha variant: A case series G6PD Ilesha variant in Pediatric patients.

G6PD activity in pediatric patients with the G6PD Ilesha variant: A case series G6PD Ilesha variant in Pediatric patients.

Journal: Clinical biochemistry

Published: February 10, 2026

Somatic UBA1 mutations in pediatric MDS/AML: first cases suggest distinct pathogenesis from adult VEXAS syndrome.

Somatic UBA1 mutations in pediatric MDS/AML: first cases suggest distinct pathogenesis from adult VEXAS syndrome.

Journal: Blood neoplasia

Published: February 09, 2026

Clonal Evolution of Pediatric Acute Myeloid Leukemia and Its Contribution to Disease Relapse.

Clonal Evolution of Pediatric Acute Myeloid Leukemia and Its Contribution to Disease Relapse.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.

Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.

Journal: JCO precision oncology

Published: October 02, 2025

Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia.

Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia.

Journal: Haematologica

Published: September 10, 2025

Pediatric T-Lymphoblastic Leukemia With Aberrant B-Cell Marker Expression: A Potential Role for Targeted Therapy.

Pediatric T-Lymphoblastic Leukemia With Aberrant B-Cell Marker Expression: A Potential Role for Targeted Therapy.

Journal: EJHaem

Published: September 06, 2025

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Journal: Blood

Published: July 23, 2025

Showing 1-12 of 233

Last Updated: 09/26/2026